Success Metrics

Clinical Success Rate

83.6%

Based on 56 completed trials

Completion Rate

84%(56/67)

Active Trials

23(17%)

Results Posted

45%(25 trials)

Terminated

11(8%)

Phase Distribution

Ph phase_3

Ph phase_2

Ph early_phase_1

Ph not_applicable

110

83%

Ph phase_1

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution132 total trials

Early Phase 1First-in-human

2(1.5%)

Phase 1Safety & dosage

4(3.0%)

Phase 2Efficacy & side effects

11(8.3%)

Phase 3Large-scale testing

5(3.8%)

N/ANon-phased studies

110(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

77.8%

56 of 72 finished

Non-Completion Rate

22.2%

16 ended early

Currently Active

trials recruiting

Total Trials

132

all time

Status Distribution

Active(36)

Completed(56)

Terminated(16)

Other(24)

Detailed Status

Completed56

Recruiting23

unknown22

Not yet recruiting12

Terminated11

Withdrawn5

Development Timeline

Analytics

Development Status

Total Trials

132

Active

Success Rate

83.6%

Most Advanced

Phase 3

Trials by Phase

Early Phase 12 (1.5%)

Phase 14 (3.0%)

Phase 211 (8.3%)

Phase 35 (3.8%)

N/A110 (83.3%)

Trials by Status

terminated118%

withdrawn54%

unknown2217%

completed5642%

enrolling_by_invitation11%

not_yet_recruiting129%

recruiting2317%

suspended22%

Recent Activity

23 active trials

Showing 5 of 132

completednot_applicable

Behavioral Impact and Neural Correlates of Network-based Brain Stimulation in Schizophrenia

NCT07190352

completednot_applicable

Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neuromodulation in Depression

NCT05224063

recruitingnot_applicable

Clinical Trials (132)

Showing 20 of 132 trialsScroll for more

NCT07190352Not Applicable

Behavioral Impact and Neural Correlates of Network-based Brain Stimulation in Schizophrenia

Completed

NCT05224063Not Applicable

Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neuromodulation in Depression

Completed

NCT05832567Not Applicable

Mechanisms of Open and Hidden Placebo in Stroke Recovery

Recruiting

NCT07683767Not Applicable

Transcranial Magnetic Stimulation in Laryngeal Dystonia

Not Yet Recruiting

NCT07666477Not Applicable

rTMS and Olfactory Training for Parkinson's Disease

Completed

NCT07653256Not Applicable

HF-rTMS Primed Balance Training on Corticomotor Excitability, Balance, and Gait in Parkinson's

Not Yet Recruiting

NCT05872243Not Applicable

pBFS Guided rTMS Treating Mild Alzheimer's Disease(AD)

Completed

NCT07634835Not Applicable

Transcranial Magnetic Stimulation for Adolescents and Young Adults With Cannabis Use Disorder

Not Yet Recruiting

NCT06395649Not Applicable

Personalized Treatment by rTMS in Chronic Pain

Completed

NCT05864313Not Applicable

Gaze and Gait Training With rTMS

Not Yet Recruiting

NCT06112652Not Applicable

Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique

Suspended

NCT06538311Early Phase 1

Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease

Recruiting

NCT07567261Not Applicable

Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation and Expressive Writing for Post-Traumatic Stress

Not Yet Recruiting

NCT07561229Not Applicable

Effects of Repetitive Transcranial Magnetic Stimulation on Two Cerebellar Targets

Not Yet Recruiting

NCT05426967Not Applicable

rTMS for Military TBI-related Depression

Recruiting

NCT01352910Not Applicable

rTMS and Functional Paralysis

Completed

NCT04903028Not Applicable

RTMS Targets Neural Circuits for Smoking Cessation

Recruiting

NCT04142320Phase 1

Closed-loop Optimized rTMS for Depression

Completed

NCT07112105Not Applicable

Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder

Not Yet Recruiting

NCT04188067Not Applicable

TMS for the Treatment of Primary Progressive Aphasia

Completed

Drug Details

Intervention Type: DEVICE
Total Trials: 132